Anxiety Disorders and Depression Treatment Market 2021 Top Companies, CAGR Status, Growth Factors for Business Development and Forecast to 2027 – Eli Lilly and Company, Forest Laboratories, Inc., VistaGen Therapeutics, AstraZeneca PLC – KSU | The Sentinel Newspaper

Anxiety Disorders and Depression Treatment Market is valued at USD 16.83 Billion in 2018 and expected to reach USD 20.97 Billion by 2025 with the CAGR of 3.19% over the forecast period.

Rising mental health issues such as depression, anxiety disorders, schizophrenia and growing geriatric population are boosting the global market for anxiety disorders and depression treatment.

Get Sample of This Report@

Scope of the Report:

Conditions of depression and anxiety are the most prevalent psychological conditions affecting a large population across the globe. Depression is linked to an emotional state which further affects the individual concerned actions, thoughts and sometimes sleeping patterns. Depression is a brain related psychiatric condition which includes feeling depressed and exhausted, losing motivation and having trouble enjoying every day routine activities. Depression exists mainly because of causes like social isolation and stressful work climate. While anxiety is a natural response to stress that can be helpful in certain cases. Anxiety disorders and depression are distinct, but depressed people frequently experience anxiety disorder like symptoms such as nervousness, irritability, sleeping and concentration issues. Persons with anxiety feeling may interfere with everyday tasks such as job performance, school work and relationships. Anxiety disorders vary from natural feelings of nervousness or anxiety, which include extreme fear or anxiety. High anxiety rates contribute to anxiety disorders that include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic stress-based disorder. There are various effective treatments are available for moderate and severe depression and anxiety. Psychological treatments may be provided by health care providers such as behavioral activation, cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) or antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs). Specific psychological treatment methods like face-to-face psychological therapies are also provided.

The regions covered in global anxiety disorders and depression treatment market reports are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, global market is sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

The global anxiety disorders and depression treatment market is segmented on the basis of product, indication and region and country level. On the basis of product, the global anxiety disorders and depression treatment market are classified into drugs, therapy and devices. Based on indication, the anxiety disorders and depression treatment market is classified into major depressive disorder, obsessive- compulsive disorder, phobias and traumatic stress disease.

Global Anxiety Disorders and Depression Treatment Market Dynamics –

Rising mental health issues such as depression, anxiety disorders, schizophrenia is the key driver for anxiety disorders and depression treatment market. According to WHO, depression will affect around 264 million people of all ages worldwide in 2020. Depression at its worst can lead to suicide. Every year around 800,000 people die from suicide. According to World Health Organization (WHO), depression currently affects an estimated 350 million people worldwide. Depression affects men between 10 % – 15 % and women between 10 % – 25 %. According to an analysis from the National Center for Health Statistics  in 2017  the 16.6 % of people aged 40 to 59, 7.8 % of people those aged 20 to 39 and 3.4 % of teenagers aged 12 to 19 uses antidepressants drugs. Worldwide, the prevalence of anxiety disorders varies from 2.5 % to 7 % per country. An estimated 284 million people globally reported an anxiety disorder in 2017, making it the most common neurodevelopmental or mental health condition. Approximately 63 % which account nearly 179 million were female, compared to 105 million.

Anxiety Disorders and Depression Treatment Companies:

Global anxiety disorders and depression treatment market reports cover prominent players,

  • Eli Lilly and Company
  • Forest Laboratories, Inc.
  • VistaGen Therapeutics
  • AstraZeneca PLC
  • Lundbeck A/S
  • Sanofi-Aventis
  • Merck Co., Inc.
  • EverInsight Therapeutics Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Johnson Johnson
  • Others

Anxiety Disorders and Depression Treatment Market Regional Analysis –

In North America, the global anxiety disorders and depression treatment market is highly attractive due rise in anxiety disorder incidence rate, sedentary lifestyle and stressful work environments are the main factors responsible for rising cases of anxiety disorders. Depression affects around 1 in every 5 individuals in the US, according to CDC. It is estimated that in the United States around 16.2 million adults who accounts approximately 6.7 % of American adults, have experienced at least one major depressive disorder. Anxiety disorders are the most prevalent mental condition in the United States; people with age 18 and older in the United States affected by anxiety around 40 million which account 18.1 % of the population per year.

Anxiety Disorders and Depression Treatment Market Segmentation –

By Product: Drugs, Therapy, Devices

By Indication: Major Depressive Disorder, Obsessive- Compulsive Disorder, Phobias And Traumatic Stress Disease

Full Research Report @

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at